Literature DB >> 781165

Priming effect of luteinizing hormone releasing factor elicited by preoptic stimulation and by intravenous infusion and multiple injections of the synthetic decapeptide.

G Fink, S A Chiappa, M S Aiyer.   

Abstract

We have investigated whether the priming effect of LH-RF can be elicited by electrical stimulation of the medial preoptic area, or by i.v. infusion or multiple i.v. injections of the synthetic decapeptide. All experiments were carried out on animals anaesthetized with sodium pentobarbitone at 13.30 h. In pro-oestrous rats, the LH response to the second of two electrical stimuli, 15 min in duration and separated by 60 min, was significantly greater than the response to the first stimulus. When synthetic LH-RF was infused at a constant rate for 90 min, plasma LH increased gradually for the first 45-60 min after which it increased markedly. This enhanced secretion of LH did not occur in rats which were infused with the same total dose of LH-RF, either 15 or 75 ng/100 g body wt, over periods of 45 min or less. When a dose of 15 ng LH-RF/100 g body wt was administered in six divided doses by i.v. injections, each separated by 15 min, there was a marked increase in plasma LH after 75 min. The profile of the mean plasma LH concentration in rats subjected to preoptic stimulation for 90 min was similar to that in rats infused for 90 min with LH-RF, but the variation in response was much greater in the stimulated rats. These results indicate that the priming effect can be elicited by endogenous as well as synthetic LH-RF, and that whether LH-RF reaches the pituitary at a constant rate or in a pulsatile manner the factor is capable of significantly increasing the responsiveness of the gonadotrophs. The relevance of these findings with respect to the development of the spontaneous preovulatory LH surge is discussed. A priming effect could not be elicited by constant LH-RF infusion in dioestrous rats; this supports the view that steroid hormones, especially oestradiol-17phi, determine the magnitude of the effect. The LH response in male rats subjected to i.v. infusion of LH-RF was much lower than in females. Pre-treatment with oestradiol benzoate did not increase the response significantly, suggesting that this sex difference cannot be ascribed simply to low levels of plasma oestrogen in the male.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 781165     DOI: 10.1677/joe.0.0690359

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

1.  Pituitary self-priming actions of gonadotropin-releasing hormone. Kinetics of estradiol's potentiating effects on gonadotropin-releasing hormone-facilitated luteinizing hormone and follicle-stimulating hormone release in healthy postmenopausal women.

Authors:  J D Veldhuis; W S Evans; A D Rogol; L Kolp; M O Thorner; P Stumpf
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

2.  Immunoreactive luteinizing hormone releasing factor (LRF) in pituitary stalk plasma from female rats: effects of stimulating diencephalon, hippocampus and amygdala.

Authors:  S A Chiappa; G Fink; N M Sherwood
Journal:  J Physiol       Date:  1977-06       Impact factor: 5.182

3.  Electrical stimulation of the hypothalamus: new observations on the parameters necessary for ovulation in rats anaesthetised with pentobarbitone during the pro-oestrous "critical period".

Authors:  R G Dyer; L C Mayes
Journal:  Exp Brain Res       Date:  1978-11-15       Impact factor: 1.972

4.  Interrelationship between pineal gland and hypothalamic-hypophyseal complex. IV. Effect of pinealectomy on luteinizing function of rat hypophysis.

Authors:  O G Krivosheev; E A Syutkin; A S Antonov; V A Isachenkov
Journal:  Neurosci Behav Physiol       Date:  1980 Nov-Dec

5.  Relationship between duration of urethane or pentobarbitone anaesthesia in male and female rats and adenohypophyseal response to luteinising hormone-releasing hormone.

Authors:  R G Dyer; S Mansfield
Journal:  Br J Pharmacol       Date:  1980-05       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.